Please email us at [email protected] with our item No, NDC#, UPC# or the product link if you have any quetions. We are located in Oceanside, California. Search over 110,000 items by Name, Item No., NDC, UPC (without dashes) or by Mfg.Name. Please note, Prescription items can only be ordered by a Drug Manufacturer, Wholesaler, Hospital, Governmental Medical Facility, VA, Pharmacy, Physician, Physician Assistant, Nurse Practitioner, Dentist, Podiatrist, Optometrist, Veterinarian, Naturopath, Licensed Lab, Physical Therapist & Pharmacist in their scope of practice. No order will ship, unless you you have provided us the Medical License (and DEA Lic. in case of controlled drug) and we had verified that. Rx items can only be shipped to AZ, AR, CA, CT, DE, FL, GA, GU, HI, IL, KS, KY, LA, ME, MA, MI, NJ, NY, PA, PR, TX, TN, VA, WA, WI and WV. If you are an International Physician or Pharmacist, please contact us before ordering.


Menu

Rx Item-ANDEXXA andexanet alfa injection DSHP 200MG POWDER VIAL 4X1 EA

NDC No.69853-0102-01 69853-102-01 6985310201 69853010201    UPC/GTIN No. 3-69853-01021-6 369853010216 369853-010216   MPN 010201 NDC No.69853-0102-01 69853-102-01 6985310201 69853010201    UPC/GTIN No. 3-69853-01021-6 369853010216 369853-010216   MPN 010201 Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scopWant to do Research on this Med or need a large quantity? Email Details with quantity required to:sales@AmericanPharmaWholesale.comVisit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.NDC No.69853-0102-01 69853-102-01 6985310201 69853010201    UPC/GTIN No. 3-69853-01021-6 369853010216 369853-010216   MPN 010201

Rx Item-ANDEXXA andexanet alfa injection DSHP 200MG POWDER VIAL 4X1 EA

$12000.00$11900.00

NDC No.69853-0102-01 69853-102-01 6985310201 69853010201 UPC/GTIN No. 3-69853-01021-6 369853010216 369853-010216 MPN 010201 No. Only Lic.-Physician, Pharmacy, Dentist, Drug Mfg, Dist., Gov, Hospital, Lic.Lab, Naturalist, Naturopath, NP, Optometrist, & Pharmacist, PA, Physical Therapist, Podiatrist, Research Co., Uni., VA, Vet & Wholesalers In Scope Of their Practice Can Order Rx Item.

Have a question?

  Out of stock, please email us with the item number or product link at [email protected] for the quantity available, current pricing and eligibility to purchase.

These highlights do not include all the information needed to use ANDEXXA safely and effectively. See Full Prescribing Information for ANDEXXA. ANDEXXA � (coagulation factor Xa (recombinant), inactivated-zhzo) Lyophilized Powder for Solution For Intravenous Injection Initial U.S. Approval: 2018 WARNING: THROMBOEMBOLIC RISKS, ISCHEMIC RISKS, CARDIAC ARREST, AND SUDDEN DEATHS SEE FULL PRESCRIBING INFORMATION FOR COMPLETE BOXED WARNING Treatment with ANDEXXA has been associated with serious and life-threatening adverse events, including: (5.1) Arterial and venous thromboembolic events Ischemic events, including myocardial infarction and ischemic stroke Cardiac arrest Sudden deaths Monitor for thromboembolic events and initiate anticoagulation when medically appropriate. Monitor for symptoms and signs that precede cardiac arrest and provide treatment as needed. INDICATIONS AND USAGE ANDEXXA, coagulation factor Xa (recombinant), inactivated-zhzo is a recombinant modified human Factor Xa (FXa) protein indicated for patients treated with rivaroxaban and apixaban, when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding. (1) This indication is approved under accelerated approval based on the change from baseline in anti-FXa activity in healthy volunteers. An improvement in hemostasis has not been established. Continued approval for this indication may be contingent upon the results of studies to demonstrate an improvement in hemostasis in patients. (1,14) Limitation of Use ANDEXXA has not been shown to be effective for, and is not indicated for, the treatment of bleeding related to any FXa inhibitors other than apixaban and rivaroxaban. (1) DOSAGE AND ADMINISTRATION For intravenous use only. Dose ANDEXXA based on the specific FXa inhibitor, dose of FXa inhibitor, and time since the patient's last dose of FXa inhibitor. (2) Administer as an intravenous (IV) bolus, with a target rate of 30 mg/min, followed by continuous infusion for up to 120 minutes. There are two dosing regimens: Dose* Initial IV Bolus Follow-On IV Infusion * The safety and effectiveness of more than one dose have not been evaluated. Low Dose 400 mg at a target rate of 30 mg/min 4 mg/min for up to 120 minutes High Dose 800 mg at a target rate of 30 mg/min 8 mg/min for up to 120 minutes DOSAGE FORMS AND STRENGTHS ANDEXXA is available as a lyophilized powder in single-use vials of 100 mg of coagulation factor Xa (recombinant), inactivated-zhzo. (3) CONTRAINDICATIONS None. (4) WARNINGS AND PRECAUTIONS Arterial and venous thromboembolic events, ischemic events, and cardiac events, including sudden death, have occurred during treatment with ANDEXXA. Resume anticoagulant therapy as soon as medically appropriate following treatment with ANDEXXA. (5.1) Re-elevation or incomplete reversal of anticoagulant activity can occur. (5.2) ADVERSE REACTIONS The most common adverse reactions (? 5%) in patients receiving ANDEXXA were urinary tract infections and pneumonia. (6.1) The most common adverse reactions (? 3%) in healthy volunteers treated with ANDEXXA were infusion-related reactions. To report SUSPECTED ADVERSE REACTIONS, contact Portola Pharmaceuticals, Inc. at 1-866-777-5947 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. See 17 for PATIENT COUNSELING INFORMATION. Revised: 5/2018

NDC No.69853-0102-01 69853-102-01 6985310201 69853010201    UPC/GTIN No. 3-69853-01021-6 369853010216 369853-010216   MPN 010201
ANDEXXA DSHP 200MG POWDER VIAL
NDC No.69853-0102-01 69853-102-01 6985310201 69853010201 UPC/GTIN No. 3-69853-01021-6 369853010216 369853-010216 MPN 010201

NDC No.69853-0102-01 69853-102-01 6985310201 69853010201    UPC/GTIN No. 3-69853-01021-6 369853010216 369853-010216   MPN 010201
ANDEXXA DSHP 200MG POWDER VIAL
NDC No.69853-0102-01 69853-102-01 6985310201 69853010201 UPC/GTIN No. 3-69853-01021-6 369853010216 369853-010216 MPN 010201

Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scop
American Pharma Wholesale
Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scop

Want to do Research on this Med or need a large quantity? Email Details with quantity required to:sales@AmericanPharmaWholesale.com
Buy More Save More!
Want to do Research on this Med or need a large quantity? Email Details with quantity required to:[email protected]

Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.
AmericanPharmaWholesale.com
Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.

NDC No.69853-0102-01 69853-102-01 6985310201 69853010201    UPC/GTIN No. 3-69853-01021-6 369853010216 369853-010216   MPN 010201
ANDEXXA DSHP 200MG POWDER VIAL
NDC No.69853-0102-01 69853-102-01 6985310201 69853010201 UPC/GTIN No. 3-69853-01021-6 369853010216 369853-010216 MPN 010201